MammoVerse: Clinicians Focus Group

Part of paid clinical trials in Orlando, Florida.

Sponsor
University of Central Florida
Study ID
NCT07644845
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The purpose of this study is to gather insights from clinicians who provide care to women diagnosed with breast cancer in Florida in order to identify gaps in emotional and mental health support encountered throughout the cancer care continuum. Clinicians will participate in virtual focus group discussions and complete a brief online demographic questionnaire. By capturing clinicians' perspectives on unmet psychosocial needs, barriers to support, and opportunities to improve patient-centered care, this study aims to inform the refinement of MammoVerse, an AI-based digital support platform intended to enhance emotional well-being, peer connection, and healthcare engagement among women facing breast cancer. This study offers preliminary data to inform the development of the MammoVerse AI platform later.

Key Dates

Start date
Feb 26, 2026
Status verified
Jun 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
12 participants (estimated)

Primary Outcome Measure

Clinician Based Focus Group to assess Emotional and Psychosocial Experiences of Women Diagnosed with Breast Cancer [ Time Frame: 6 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Central FloridaOrlandoFlorida32827-

Find similar trials in Orlando, FL

By condition

Related Studies